tirzepatide and nash Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review SYNERGY-NASH: Tirzepatide, a GIP/GLP-1 RA,

Thanh Hng gii thch, d l nhn hng dc m phm cn non tr x s Ph Tang, Sakura vi s mnh mang n sc p, sc kho v hnh phc cho mi ngi, c mt ti Vit Nam t 2014, Dc m phm Sakura c hng triu ph n Vit s dng v tin tng

It also enhances growth hormone secretion without significantly altering cortisol or other hormone levels, making it an effective alternative for those looking to maintain youthful vitality and manage body composition effectively.

Besides its glucose-lowering and anti-obesity effects, tirzepatide has been reported to have potential cardiovascular benefits

This is remarkable progress given the historical trends with previous anti-obesity medications used (i.e